1-8 of 8
Chengfeng Bi, MD, PhD
Close
Sort by
Journal Articles

Targeting Oncoprotein Translation with Rocaglates in MYC-Driven Lymphoma

Xuan Zhang, BMBS, Chengfeng Bi, MD PhD, Ting Lu, MD PhD, Ting Yue, Weiwei Zhang, PhD, Xiaoyan Zhang, MD, Wang Cheng, MD, Tian Tian, MD, Matthew A. Lunning, DO, Julie M. Vose, MDMBA, Jerry Pelletier, PhD, John A Porco, Jr., PhD, Jianguo Tao, MD PhD, Kai Fu, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 38.
https://doi.org/10.1182/blood-2018-99-117659
Published: 2018
Journal Articles

Pharmacoproteomics Identifies PLK1 As Vulnerability for Aggressive B-Cell Lymphomas

Yuan Ren, PhD, Chengfeng Bi, MD PhD, Xiaohong Zhao, MD PhD, Tint Lwin, MD PhD, Wang Cheng, MD, Ji Yuan, Ariosto Siqueira Silva, PhD, Bijal D. Shah, MD, Bin Fang, PhD, Tao Li, John M. Koomen, PhD, Huijuan Jiang, MD, Julio C. Chavez, MD, Lan V. Pham, PhD, Praneeth Reddy Sudalagunta, PhD, Lixin Wan, Xuefeng Wang, PhD, William S. Dalton, PhD MD, Lynn C. Moscinski, MD, Kenneth H. Shain, MD PhD, Julie M. Vose, MD MBA, John Cleveland, PhD, Eduardo Sotomayor, MD, Kai Fu, MD PhD, Jianguo Tao, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2853.
https://doi.org/10.1182/blood-2018-99-118004
Published: 2018
Journal Articles

Chimeric Antigen Receptor-Engineered Exosome As a Drug Delivery System in Mantle Cell Lymphoma

Huijing Bao, PhD, Chengfeng Bi, MD PhD, Wei Li, PhD, Xuhan Zhang, Huilai Zhang, Bin Meng, Kai Fu, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5561.
https://doi.org/10.1182/blood.V130.Suppl_1.5561.5561
Published: 2017
Journal Articles

Long Non Coding RNA Signatures with Diagnostic and Prognostic Significance in Aggressive B-Cell Lymphoma

Jiayu Yu, Alyssa Bouska, PhD, Waseem Lone, PhD, Chengfeng Bi, MD PhD, Tayla Heavican, Kai Fu, MD PhD, Timothy C. Greiner, MD, Wing Chung Chan, MD, Javeed Iqbal, PhD
Journal: Blood
Blood (2016) 128 (22): 1759.
https://doi.org/10.1182/blood.V128.22.1759.1759
Published: 2016
Journal Articles

Comprehensive Genomic Analysis of Adult Burkitt Lymphoma Identifies the B-Cell Receptor Signaling Pathway As a Potential Therapeutic Target

Alyssa Bouska, PhD, Chengfeng Bi, MD PhD, Waseem Lone, PhD, Weiwei Zhang, PhD, Ambreen Kedwaii, MS, Tayla B Heavican, BS, Cynthia M Lachel, BS, Jiayu Yu, MD MS, Kai Fu, MD PhD, Roberto A. Ferro, MD, Nanees Eldorghamy, MD, Timothy C. Greiner, MD, Julie M Vose, MD, Dennis D Weisenburger, MD, Randy D Gascoyne, MD, Andreas Rosenwald, MD, German Ott, Elias Campo, MD PhD, Lisa M Rimsza, MD, Elaine S. Jaffe, MD, Rita M Braziel, MD, Reiner Siebert, Rodney R. Miles, MD PhD, Sandeep Dave, MD, Anupama Reddy, Timothy W. McKeithan, MD PhD, Louis M. Staudt, MD PhD, Michael R Green, PhD, Wing Chung Chan, MD, Javeed Iqbal, MS, PhD
Journal: Blood
Blood (2016) 128 (22): 4095.
https://doi.org/10.1182/blood.V128.22.4095.4095
Published: 2016
Journal Articles

Prediction and Optimization of the Therapeutic Effect of mTOR Inhibitors in Aggressive B-Cell Lymphomas

Chengfeng Bi, MD, PhD, Xiaoyan Zhang, MD, Zhang Xuan, MD, Wing C Chan, MD, PhD, Timothy McKeithan, MD, PhD, Kai Fu, MD, PhD
Journal: Blood
Blood (2015) 126 (23): 4441.
https://doi.org/10.1182/blood.V126.23.4441.4441
Published: 2015
Journal Articles

Aberrant Expression of IL-22 Receptor 1 and IL-22 Stimulation Increase the Activation of STAT3 and ERK1/2 in ABC-DLBCL Cells

Ting Lu, MD, Peng Li, MD, PhD, Chengfeng Bi, MD, PhD, Shuang Yu, MD, Daoxin Ma, MD, PhD, Kai Fu, MD PhD, Chunyan Ji, MD PhD
Journal: Blood
Blood (2015) 126 (23): 2664.
https://doi.org/10.1182/blood.V126.23.2664.2664
Published: 2015
Journal Articles

The Combination Of 2-DG and Metformin Inhibits The mTORC1 Pathway and Suppresses Aggressive B Cell Lymphoma Growth and Survival

Chengfeng Bi, MD, PhD, Kai Fu, MD, PhD, Chunsun Jiang, PhD, Xin Huang, PhD, Wing Chung Chan, MD, Timothy McKeithan, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1665.
https://doi.org/10.1182/blood.V122.21.1665.1665
Published: 2013